Who Paid My Doc
Veeral Shah
Pediatric Ophthalmology and Strabismus Specialist Cincinnati, OH Medical Doctor
NPI 1528387610 CMS profile 1089822
3333 Burnet Ave, Cincinnati, OH 45229
General payments
$696
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$4,878
Through program year 2021, Veeral Shah of Cincinnati, OH is reported in the CMS Open Payments database as having received $696 across 2 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,878 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 72nd percentile of Pediatric Ophthalmology and Strabismus Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $129 | 1 | |
| 2019 | General | $567 | 1 |
Beside peers
- Veeral Shah
- Pediatric Ophthalmology and Strabismus Specialist median
- Middle half of Pediatric Ophthalmology and Strabismus Specialist
- National median
In program year 2025, general payments to Veeral Shah were reported at $0. Among 124 Pediatric Ophthalmology and Strabismus Specialist profiles paid that year, the median was $118 and the middle half received between $36 and $253.
Show as a table
| Year | Veeral Shah | Pediatric Ophthalmology and Strabismus Specialist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $567 | $106 | $24–$276 | $163 |
| 2020 | $0 | $54 | $19–$171 | $114 |
| 2021 | $129 | $118 | $25–$225 | $132 |
| 2022 | $0 | $97 | $40–$324 | $149 |
| 2023 | $0 | $139 | $78–$441 | $160 |
| 2024 | $0 | $114 | $35–$313 | $164 |
| 2025 | $0 | $118 | $36–$253 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Ophthalmology and Strabismus Specialist in Ohio
Robert Bloom
Pediatric Ophthalmology and Strabismus Specialist · Dayton, OH
Michael Bloom
Pediatric Ophthalmology and Strabismus Specialist · Dayton, OH
Syeda Ahmed Naqvi
Pediatric Ophthalmology and Strabismus Specialist · Blue Ash, OH
Luxme Hariharan
Pediatric Ophthalmology and Strabismus Specialist · Dayton, OH
Allison Babiuch
Pediatric Ophthalmology and Strabismus Specialist · Cleveland, OH
Marina Eisenberg
Pediatric Ophthalmology and Strabismus Specialist · Beachwood, OH
Related records
Pediatric Ophthalmology and Strabismus Specialist in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Ophthalmology and Strabismus Specialist
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.